Microvascular and Cellular Dysfunctions in Alzheimer's Disease: an Integrative Analysis Perspective

Overview

Journal Sci Rep

Specialty Science

Date 2024 Sep 9

PMID 39251797

Authors

Mengjie Li

Xiaoyan Hao

Zhengwei Hu

Jie Tian

Jingjing Shi

Dongrui Ma

Mengnan Guo

Shuangjie Li

Chunyan Zuo

Yuanyuan Liang

Mibo Tang

Chengyuan Mao

Yuming Xu

Changhe Shi

Affiliations

Soon will be listed here.

Abstract

Alzheimer's disease (AD) is the most common cause of dementia, characterized by memory loss, cognitive decline, personality changes, and various neurological symptoms. The role of blood-brain barrier (BBB) injury, extracellular matrix (ECM) abnormalities, and oligodendrocytes (ODCs) dysfunction in AD has gained increasing attention, yet the detailed pathogenesis remains elusive. This study integrates single-cell sequencing of AD patients' cerebrovascular system with a genome-wide association analysis. It aims to elucidate the associations and potential mechanisms behind pericytes injury, ECM disorder, and ODCs dysfunction in AD pathogenesis. Finally, we identified that abnormalities in the pericyte PI3K-AKT-FOXO signaling pathway may be involved in the pathogenic process of AD. This comprehensive approach sheds new light on the complex etiology of AD and opens avenues for advanced research into its pathogenesis and therapeutic strategies.

Citing Articles

Differential Transcriptional Programs Reveal Modular Network Rearrangements Associated with Late-Onset Alzheimer's Disease.

Perez-Gonzalez A, Anda-Jauregui G, Hernandez-Lemus E Int J Mol Sci. 2025; 26(5).

PMID: 40076979 PMC: 11900169. DOI: 10.3390/ijms26052361.

Is the Relationship Between Cardiovascular Disease and Alzheimer's Disease Genetic? A Scoping Review.

Moore A, Ritchie M Genes (Basel). 2025; 15(12).

PMID: 39766777 PMC: 11675426. DOI: 10.3390/genes15121509.

References

Scheltens P, De Strooper B, Kivipelto M, Holstege H, Chetelat G, Teunissen C . Alzheimer's disease. Lancet. 2021; 397(10284):1577-1590. PMC: 8354300. DOI: 10.1016/S0140-6736(20)32205-4. View

Hardy J, Selkoe D . The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science. 2002; 297(5580):353-6. DOI: 10.1126/science.1072994. View

Maccioni R, Farias G, Morales I, Navarrete L . The revitalized tau hypothesis on Alzheimer's disease. Arch Med Res. 2010; 41(3):226-31. DOI: 10.1016/j.arcmed.2010.03.007. View

Terry Jr A, Buccafusco J . The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: recent challenges and their implications for novel drug development. J Pharmacol Exp Ther. 2003; 306(3):821-7. DOI: 10.1124/jpet.102.041616. View

Sweeney M, Sagare A, Zlokovic B . Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat Rev Neurol. 2018; 14(3):133-150. PMC: 5829048. DOI: 10.1038/nrneurol.2017.188. View

Zhao Z, Nelson A, Betsholtz C, Zlokovic B . Establishment and Dysfunction of the Blood-Brain Barrier. Cell. 2015; 163(5):1064-1078. PMC: 4655822. DOI: 10.1016/j.cell.2015.10.067. View

Ishii M, Iadecola C . Risk factor for Alzheimer's disease breaks the blood-brain barrier. Nature. 2020; 581(7806):31-32. PMC: 8018585. DOI: 10.1038/d41586-020-01152-8. View

Sweeney M, Zhao Z, Montagne A, Nelson A, Zlokovic B . Blood-Brain Barrier: From Physiology to Disease and Back. Physiol Rev. 2018; 99(1):21-78. PMC: 6335099. DOI: 10.1152/physrev.00050.2017. View

Wang D, Chen F, Han Z, Yin Z, Ge X, Lei P . Relationship Between Amyloid-β Deposition and Blood-Brain Barrier Dysfunction in Alzheimer's Disease. Front Cell Neurosci. 2021; 15:695479. PMC: 8326917. DOI: 10.3389/fncel.2021.695479. View

10.

Lepelletier F, Mann D, Robinson A, Pinteaux E, Boutin H . Early changes in extracellular matrix in Alzheimer's disease. Neuropathol Appl Neurobiol. 2015; 43(2):167-182. DOI: 10.1111/nan.12295. View

11.

Sun Y, Xu S, Jiang M, Liu X, Yang L, Bai Z . Role of the Extracellular Matrix in Alzheimer's Disease. Front Aging Neurosci. 2021; 13:707466. PMC: 8430252. DOI: 10.3389/fnagi.2021.707466. View

12.

Chen W, Lu A, Craessaerts K, Pavie B, Sala Frigerio C, Corthout N . Spatial Transcriptomics and In Situ Sequencing to Study Alzheimer's Disease. Cell. 2020; 182(4):976-991.e19. DOI: 10.1016/j.cell.2020.06.038. View

13.

Armulik A, Genove G, Mae M, Nisancioglu M, Wallgard E, Niaudet C . Pericytes regulate the blood-brain barrier. Nature. 2010; 468(7323):557-61. DOI: 10.1038/nature09522. View

14.

Sweeney M, Ayyadurai S, Zlokovic B . Pericytes of the neurovascular unit: key functions and signaling pathways. Nat Neurosci. 2016; 19(6):771-83. PMC: 5745011. DOI: 10.1038/nn.4288. View

15.

Lin Z, Sur S, Liu P, Li Y, Jiang D, Hou X . Blood-Brain Barrier Breakdown in Relationship to Alzheimer and Vascular Disease. Ann Neurol. 2021; 90(2):227-238. PMC: 8805295. DOI: 10.1002/ana.26134. View

16.

Halliday M, Rege S, Ma Q, Zhao Z, Miller C, Winkler E . Accelerated pericyte degeneration and blood-brain barrier breakdown in apolipoprotein E4 carriers with Alzheimer's disease. J Cereb Blood Flow Metab. 2015; 36(1):216-27. PMC: 4758554. DOI: 10.1038/jcbfm.2015.44. View

17.

Sengillo J, Winkler E, Walker C, Sullivan J, Johnson M, Zlokovic B . Deficiency in mural vascular cells coincides with blood-brain barrier disruption in Alzheimer's disease. Brain Pathol. 2012; 23(3):303-10. PMC: 3628957. DOI: 10.1111/bpa.12004. View

18.

Miners J, Schulz I, Love S . Differing associations between Aβ accumulation, hypoperfusion, blood-brain barrier dysfunction and loss of PDGFRB pericyte marker in the precuneus and parietal white matter in Alzheimer's disease. J Cereb Blood Flow Metab. 2017; 38(1):103-115. PMC: 5757436. DOI: 10.1177/0271678X17690761. View

19.

Montagne A, Nation D, Sagare A, Barisano G, Sweeney M, Chakhoyan A . APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline. Nature. 2020; 581(7806):71-76. PMC: 7250000. DOI: 10.1038/s41586-020-2247-3. View

20.

Nikolakopoulou A, Montagne A, Kisler K, Dai Z, Wang Y, Huuskonen M . Pericyte loss leads to circulatory failure and pleiotrophin depletion causing neuron loss. Nat Neurosci. 2019; 22(7):1089-1098. PMC: 6668719. DOI: 10.1038/s41593-019-0434-z. View